Innovative Preservation Solutions X-Therma Inc. specializes in advanced biopreservation technology utilizing biomimetic nanomaterials, addressing critical needs in regenerative medicine, organ transplants, and cell therapies. This presents an opportunity to collaborate with healthcare providers, biotech firms, and research institutions seeking cutting-edge preservation solutions.

Strong Funding and Recognition The company has secured significant funding, including a $22.4 million Series B round and a $13 million oversubscribed Series A investment from Methuselah Foundation, indicating investor confidence and financial stability that support sales efforts toward large research and healthcare organizations.

Active Industry Engagement X-Therma actively participates in high-profile events like Kidney Week 2025 and Johns Hopkins' 'Hopkins on the Hill,' demonstrating its thought leadership and opening avenues for partnerships with hospitals, organ donation organizations, and medical research institutions.

Leadership with Industry Expertise The appointment of Neil Warma to the board, with over 25 years of healthcare entrepreneurship experience, enhances strategic direction and credibility, which can be leveraged when engaging with high-level decision-makers in biotechnology and regenerative medicine sectors.

Growing Market Presence With a revenue estimate of $10M to $25M and recent recognition such as a finalist in the Fierce Innovation Award, X-Therma is positioning itself as a significant player in biotech innovation, creating opportunities to introduce its biosolutions to organizations focused on organ preservation, biobanking, and regenerative therapies.